Arcus Biosciences.

No events began in the chosen period. Widen it, or reset.

• SEC Structural
  DHS, DOJ, and SEC formed a joint initiative to establish a Trade Fraud Task Force, setting standards for compliance.
  Moves Arcus Biosciences

  Mon 17:57
• Goldman Sachs Mentioned together
  Goldman Sachs, Morgan Stanley, JPMorgan Chase, and Bank of America are competing in the global investment banking sector.
  Moves Arcus Biosciences

  Mon 17:24
• FDA Operational
  Generic medicine services are seeking approval for launch from the FDA.
  Moves Arcus Biosciences

  Mon 17:49
• Securities and Exchange Commission Structural
  BlackRock, the manager of the iShares Core MSCI EAFE ETF, has made required filings with the Securities and Exchange Commission regarding institutional holdings.
  Moves Arcus Biosciences

  Mon 16:42
• Morgan Stanley Structural
  Financial firms including Morgan Stanley, Truist Financial, Jefferies Financial Group, and CIBC issued rating and price objective updates for Clearway Energy.
  Moves Arcus Biosciences

  Mon 17:33
• Leerink partners Operational
  Analyst firm set price targets for Leerink partners' client, Twist Bioscience, on June 26, 2026. Concurrently, the CEO sold shares due to tax withholding obligations.
  Moves Arcus Biosciences

  Mon 08:52

• SEC Structural

  Arcus Biosciences operates under the regulatory oversight of the SEC, requiring specific institutional purchase filings and disclosures.

  Well supportedJul 14
  Arcus Biosciences → SEC

  SEC → Arcus Biosciences
• Goldman Sachs Mentioned together

  Goldman Sachs provides market analysis and target price recommendations for Arcus Biosciences.

  Some supportAug 8
  Arcus Biosciences → Goldman Sachs

  Goldman Sachs → Arcus Biosciences
• Bristol-Myers Squibb Transactional

  Arcus Biosciences established a formal collaboration agreement with Bristol-Myers Squibb.

  Some supportAug 9
  Arcus Biosciences → Bristol-Myers Squibb

  Bristol-Myers Squibb → Arcus Biosciences
• FDA Operational

  Arcus Biosciences engages with the FDA to discuss its study plans as part of the regulatory process.

  Some supportAug 9
  Arcus Biosciences → FDA

  FDA → Arcus Biosciences
• Securities and Exchange Commission Structural

  Arcus Biosciences is subject to formal regulatory requirements and reporting obligations imposed by the Securities and Exchange Commission.

  Some supportSep 4
  Arcus Biosciences → Securities and Exchange Commission

  Securities and Exchange Commission → Arcus Biosciences
• Leerink partners Operational

  Leerink partners' analyst reports and target prices are observed to influence Arcus Biosciences' stock rating and price.

  Some supportJul 20
  Arcus Biosciences → Leerink partners

  Leerink partners → Arcus Biosciences
• Morgan Stanley Structural

  Morgan Stanley provides professional market research and price target analysis on Arcus Biosciences.

  Some supportAug 12
  Arcus Biosciences → Morgan Stanley

  Morgan Stanley → Arcus Biosciences
• Wells Fargo Mentioned together

  Wells Fargo has provided an investment rating (Equal Weight) on Arcus Biosciences.

  Some supportAug 8
  Arcus Biosciences → Wells Fargo

  Wells Fargo → Arcus Biosciences